COLINZ LABORATORIES LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 1.7226 crores during the period ended December 31, 2022 as compared to Rs. 1.9616 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.1026 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 0.1166 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.41 for the period ended December 31, 2022 as compared to Rs. 0.46 for the period ended September 30, 2022.
Total Income | ₹1.7226 crs | ₹1.9616 crs | -12.18% |
Net Profit | ₹0.1026 crs | ₹0.1166 crs | -12.01% |
EPS | ₹0.41 | ₹0.46 | -10.87% |
Financial Results (Q3 FY2023) - YoY Comparison The company has reported total income of Rs.1.7226 crores during the period ended December 31, 2022 as compared to Rs.1.6207 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.1026 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.0856 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.41 for the period ended December 31, 2022 as compared to Rs.0.19 for the period ended December 31, 2021.
Total Income | ₹1.7226 crs | ₹1.6207 crs | 6.29% |
Net Profit | ₹0.1026 crs | ₹0.0856 crs | 19.86% |
EPS | ₹0.41 | ₹0.19 | 115.79% |
Financial Results (9 Months Ended FY2023) - YoY Comparison The company has reported total income of Rs.5.5636 crores during the 9 Months period ended December 31, 2022 as compared to Rs.5.4922 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.3295 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.2675 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.1.31 for the 9 Months period ended December 31, 2022 as compared to Rs.0.59 for the 9 Months period ended December 31, 2021.
Total Income | ₹5.5636 crs | ₹5.4922 crs | 1.30% |
Net Profit | ₹0.3295 crs | ₹0.2675 crs | 23.18% |
EPS | ₹1.31 | ₹0.59 | 122.03% |
Shares of COLINZ LABORATORIES LTD. was last trading in BSE at Rs. 44.55 as compared to the previous close of Rs. 44.60. The total number of shares traded during the day was 2413 in over 35 trades.
The stock hit an intraday high of Rs. 44.60 and intraday low of 42.50. The net turnover during the day was Rs. 106054.00.
Source : Equity Bulls
Keywords
ColinzLaboratories
Q3FY23
9MFY23
ResultUpdate